A s bstract. The interaction of bradykinin (BK) with its specific receptors on intact cultured human fibroblasts results in production ofprostaglandins, including prostacyclin (PG12), and accumulation of cyclic AMP. Incubation of cells with 1 ,tM BK for 5 min at 37°C led to a marked reduction (75-90%) in BK-induced PGI2 release and in total number of [3H]BK-binding sites with no change in dissociation constant (6.1 and 7.6 nM for control and BK-treated cells, respectively). The decrease in receptor number did not result from BK transferred from the first incubation into the binding assay. BK-induced receptor loss was temperature dependent; exposure of cells to BK at 40C had little or no effect on receptor number. After incubation with BK for _ 15 min, further incubation in the absence of BK for 30 min at 370C almost completely restored both receptor number and BK-induced PGI2 release. With more prolonged exposure to BK (>1 h), restoration of receptors was inversely related to the length of exposure and the concentration ofBK. Recovery was unaffected by cycloheximide. During prolonged incubation without removal of BK, cells began to recover receptors by 5 h; >99% of the bradykinin initially present disappeared by 3 h. Bacitracin greatly retarded BK disappearance and totally prevented recovery. These observations provide direct evidence that the num-
Introduction
The nonapeptide (Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg) bradykinin (BK)' has effects on a number of different tissues and cellular functions and causes, for example, vasodilation and hypotension, pain, increased intestinal motility, and chloride secretion (1) (2) (3) (4) . Moreover, recent evidence suggests a role for BK as a neurotransmitter (5) . Alterations in the concentration of BK in human plasma have been reported in association with several clinical syndromes, including postgastrectomy-dumping syndrome, familial orthostatic syndromes, and carcinoid tumors (4, 6) . In intact tissues, bradykinin receptor stimulation appears to initiate a series of intracellular events including activation of phospholipases A2 and C (7, 8) , the release of prostaglandins (9) (10) (11) , and accumulation of cyclic AMP (cAMP) and cyclic guanosine monophosphate (10) (11) (12) (13) (14) . The effects of BK on accumulation of cAMP are presumably indirect, a consequence of BK-promoted release of arachidonic acid and subsequent production of prostaglandins, which activate adenylate cyclase (1 1, 13, 14) . We have recently identified specific [3HJBK-binding sites on intact human fibroblasts that are closely linked to BK-induced PGI2 formation (15) . On the basis of indirect evidence, others (11, 16) suggested the possible involvement of BK receptors in refractoriness and desensitization to BK. We report here that exposure ofthe cultured fibroblasts to BK causes disappearance or loss of specific BK receptors and that BKdegrading enzymes may play an important part in the autoregulation of these receptors, thus influencing tissue responsiveness to BK.
Methods
[2,3-Prolyl-3,4-3H(N)JBK (52 Ci/mmol) and 6- (18) . Each assay contained 100 M1 of medium or standard (10-2,000 pg), 50 Ml of 6-keto-PGF1, (7,000 cpm), 50 Ml of antiserum (diluted such that -40% of the radioligand was bound), and 0.1% of gelatin in a total volume of 400 Ml of 10 mM Tris/150 mM NaCl, pH 7.4. After incubation for 16 h at 4°C, 500 ,l of an ice-cold 0.5% charcoal/0.05% dextran mixture was added and tubes were centrifuged (1,000 g, 10 min, 4C). Supernatants containing antibody-bound 6-keto-[3H]PGF1,,, were decanted into vials for radioassay after addition of 10 ml of Aquasol.
BK remaining in the medium after incubation with fibroblasts was estimated by using a receptor-binding assay. BK (and closely related analogues) but not BK degradation products compete with [3H]BK for binding by fibroblasts in proportion to their biological activity (15) . Samples (1.5 ml) of used incubation medium containing BK or appropriate standards (0.5-1,000 ng/ml BK) were diluted with 0.5 ml ofbuffer containing 8 mM bacitracin and frozen immediately. Samples (2 ml) were thawed on ice, diluted if necessary, mixed with 100 ,ul of 100 nM [3H]BK and incubated with fibroblasts to determine specific [3H]BK binding. BK remaining in the used medium was calculated from a standard plot of percentage of [3H]BK specifically bound vs. BK concentration.
Results
In cultured human fibroblasts, PGE, and isoproterenol, acting through their respective receptors, increase adenylate cyclase activity and thereby cause accumulation of cAMP (16) . BK presumably increases the cAMP content of these and other cells indirectly as a consequence of BK-induced prostaglandin production (10, 11, 13, 14) . Incubation of fibroblasts with 1 4M
BK at 37°C markedly reduced the rise in cAMP produced by a subsequent 5-min exposure to BK without altering responses to PGE, or isoproterenol (Table I) .
In an earlier study, (Fig. 2) . After acid treatment, the remaining 3H (presumably internalized peptides) was completely (>95%) extracted with ethanol. Radioactivity in the ethanol extract, analyzed by HPLC as described in Methods, was associated entirely with altered/degraded products of BK (data not shown). This indicates that after incubation and washing at 37°C only a negligible amount of radiolabel remains susceptible to extraction with acetic acid (and presumably is bound to the cell surface); residual radiolabel represents both internalized and degraded/altered products of BK.
With cells that had been exposed to 1 jtM BK for 15 (Fig. 4) . Exposure of cells for 15 min to 0.03, 0.3, or 3 pM BK caused -80% loss of receptors, and restoration of receptor number was virtually complete after a subsequent 60-min incubation (Fig. 5 ). After incubation with 0.3 or 3 pM BK for 60 min or more, however, a further 60-min incubation resulted in only partial restoration of [3H]BK binding (Fig. 5) . In other experiments, BK was not removed and cells began to recover [3H]BK-binding sites by 3 h; binding was restored to -50% of maximal by the eighth hour (Fig. 6 B) . In this experiment, >99% of the BK initially present disappeared in 3 h and by 5 h no BK was detectable (Fig. 6 A) . When bacitracin was present, the BK concentration was still >100 nM after 8 h and there was no recovery of [3H]BK-binding sites. The nature ofthe presumed fibroblast BK-degrading systems has not been determined. Degradation, however, does not occur in the medium as a result of peptidase secretion or leakage (unpublished observations). Inhibitor experiments and HPLC analysis of the degradation products of BK indicate that neither kininase I nor kininase II is likely to be involved (15) . During incubation at 37°C with human fibroblasts, immunoreactive substance P also disappeared, suggesting that the presumed degradative system is not specific for bradykinin (data not shown). number of binding sites was reduced but their affinity for BK was apparently unaltered. The decrease in binding sites was closely paralleled by a decrease in BK-induced PGI2 production, indicating that these high affinity specific binding sites have the functional characteristics of receptors. In addition, it would appear that in the fibroblasts virtually all BK receptors are linked to the cellular effector system, i.e., there is no significant fraction of "reserve" or "spare" receptors. Reduction in number of BK receptors and in BK-induced PGI2 release exhibited the same dependence on BK concentration. Half-maximal decreases in both were produced with -6 nM BK, a concentration approximating the Kd for the BK receptor in these cells. With several BK analogues, the rank order of potency in causing receptor loss (21) was similar to the order of potency in competing for specific [3H]BK binding or stimulating PGI2 production (15) . Thus, there is close correlation between agonist occupancy of the BK receptor and receptor loss. In addition to receptor occupancy, however, a further tem- This material consisted exclusively of altered/degraded products of BK.
BK-induced receptor loss and restoration appear to involve several processes. After brief (I15-30 min) exposure to BK, restoration of receptors was essentially complete within 30 min after removal of BK. The reappearance of BK receptors was accompanied by a parallel recovery in BK-induced PGI2 release, indicating a functional coupling of the restored receptors with prostaglandin synthesis. In contrast to the relatively rapid and complete restoration ofreceptors after briefincubation (15 min) with BK, only partial recovery of binding occurred when cells had been exposed to BK for >1 h. Recovery was inversely related to the concentration of BK as well as the duration of exposure. During prolonged incubation of fibroblasts without removal of BK, partial recovery of BK receptors (-40-60%) was observed within 6 h. Under these conditions, however, substantial degradation of BK occurred so that within 3-5 h the concentration of BK was <0.5 nM. Similar recovery of responsiveness during incubation with angiotensin II and substance P as well as BK has been reported (16) . Bacitracin, which had no effect on the binding of BK to cells or on the time course of BK-induced down-regulation, markedly retarded BK degradation and completely prevented recovery of BK receptors during an 8-h incubation. Similarly, putative BK receptors in rat uterus were reportedly decreased after infusion ofthe kininase II inhibitor Captopril (24) . Processes other than peptide degradation appear to influence the rate and extent of receptor reappearance on the cell surface, since the full complement of receptors was not restored even several hours after removal or complete destruction of BK in the incubation medium. It is of interest that recovery ofreceptors, after either brief or prolonged exposure to BK, was not inhibited by cycloheximide (21) .
The observations reported here might be described by a model in which BK receptors cycle between active (accessible to the peptide and coupled to PGI2 production) and inactive states and that prolonged receptor occupancy leads to incomplete reactivation of inactive receptors. Although the molecular mechanisms underlying these phenomena remain to be elucidated, the temperature-dependent accumulation of BK degradation products in an apparently intracellular compartment suggests that internalization of a ligand-receptor complex may be involved as is the case with several other hormones (25) (26) (27) . In the sense that BK degradation minimizes both the concentration to which cells are exposed and the duration of exposure, it could be of major importance in regulating the number of functional receptors and thereby the responsiveness of cells to the peptide. The presence of highly active degradation systems might serve to protect target tissues from developing a chronic insensitivity to BK and perhaps similar peptides. In addition to providing direct evidence that BK induces the homologous desensitization of its specific receptor as do many other peptide hormones (22, 26) , our experiments are consistent with the view that autoregulation ofthe BK receptor and its biological function is controlled by peptide-degrading systems. These findings could prove useful in understanding the impact of therapeutic interventions aimed at altering plasma or tissue content of BK (28) and might also serve as a model for the regulation of receptors for other hormones (e.g., opioid peptides, histamine) that are rapidly degraded in their target tissues.
